InfuSystem Holdings (INFU) Other financing activities (2015 - 2026)
InfuSystem Holdings' (INFU) quarterly Other financing activities came in at $6.1 million in Q1 2026, up 3764.78% YoY from $159000.0 in Q1 2025, and down 8.61% on a QoQ basis from $6.7 million in Q4 2025.
InfuSystem Holdings (INFU) Other financing activities (2015 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has 12 years of Other financing activities data on file, last reported at $6.1 million in Q1 2026.
- Quarterly Other financing activities rose 3764.78% year-over-year to $6.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $54.2 million (up 6.78% YoY) and the FY2025 annual result came in at $48.2 million, down 5.06% from the prior year.
- Other financing activities eased to $6.1 million in Q1 2026, from $6.7 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $50.4 million in Q4 2024 to a low of -$31.4 million in Q3 2024.
- A 5-year average of $9.9 million and a median of $6.4 million in 2025 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2022 — Other financing activities tumbled 184.69% — and 2023, when it surged 10285.89%.
- Tracing INFU's Other financing activities over 5 years: stood at $205000.0 in 2022, then jumped by 4175.12% to $8.8 million in 2023, then surged by 475.27% to $50.4 million in 2024, then slumped by 86.66% to $6.7 million in 2025, then declined by 8.61% to $6.1 million in 2026.
- The last three Other financing activities figures came in at $6.1 million (Q1 2026), $6.7 million (Q4 2025), and $41.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | InfuSystem Holdings | 244.87 Mn | 243.90 Mn | 21.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.50 Mn |
| Jun 30, 2026 | 7.50 Mn |
| Mar 31, 2026 | 6.15 Mn |
| Mar 31, 2026 | 6.15 Mn |
| Dec 31, 2025 | 6.72 Mn |
| Dec 31, 2025 | 6.72 Mn |
| Sep 30, 2025 | 41.34 Mn |
| Sep 30, 2025 | 41.34 Mn |
| Mar 31, 2025 | 159,000.00 |
| Mar 31, 2025 | 159,000.00 |
| Dec 31, 2024 | 50.42 Mn |
| Dec 31, 2024 | 50.42 Mn |
| Sep 30, 2024 | -31.39 Mn |
| Sep 30, 2024 | -31.39 Mn |
| Jun 30, 2024 | 31.58 Mn |
| Jun 30, 2024 | 31.58 Mn |
| Mar 31, 2024 | 186,000.00 |
| Mar 31, 2024 | 186,000.00 |
| Dec 31, 2023 | 8.76 Mn |
| Dec 31, 2023 | 8.76 Mn |